{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"\ud83e\uddec Turning Back Inflammaging: Thymulin\u2019s Immunotherapy Breakthrough","description":"\ud83e\uddec Can a thymus-derived peptide help overcome age-related resistance to cancer immunotherapy? A fascinating new study identifies thymulin as a key regulator of age-associated inflammation. In preclinical models, thymulin reduced pro-inflammatory myeloid activity, inhibited NF-\u03baB signaling, enhanced T-cell immunity, and restored responsiveness to anti-PD-L1 therapy in aged hosts. While clinical translation remains to be established, the work highlights the intriguing thymus\u2013myeloid axis as a potential therapeutic target in older adults with cancer. \ud83c\udf99\ufe0f More insights on Dr RR Baliga\u2019s Podkast for the Kurious Doc\u2014Where Curiosity Meets Clarity! ","author_name":"Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!","author_url":"http:\/\/www.MasterMedFacts.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/42187035\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/204384995"}